Angioimmunoblastic lymphadenopathy with disproteinemia (AILD) is a rare lymphoproliferative disorder. The clinical course varies and about 15-20% of the patients develop a malignant lymphoma. The association of AILD and carcinoma is very rare: only 4 cases have been reported in the literature. They are reviewed here and 1 case is described. This case is of special interest for the following reasons: (1) the exceptional length of time which elapsed between the diagnosis of AILD and the onset of an adenocarcinoma of the colon (118 months); (2) the long survival (the patient is still alive and well 140 months after the diagnosis of AILD); (3) unlike the cases reviewed, in our patient the carcinoma was diagnosed when AILD was in clinical remission, so a radical treatment was possible. In the cases previously reported, carcinomas arose in the lung (2 patients), pancreas (1 case), and stomach (1 case). The rare association of AILD and carcinoma is probably coincidental; however, the growth of solid tumors of nonlymphoid nature may be related to the impaired T cell function, and should be kept in mind in the management of patients with AILD.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000226631DOI Listing

Publication Analysis

Top Keywords

angioimmunoblastic lymphadenopathy
8
lymphadenopathy disproteinemia
8
association aild
8
aild carcinoma
8
cases reported
8
diagnosis aild
8
aild
7
case
5
disproteinemia associated
4
carcinoma
4

Similar Publications

Angioimmunoblastic T-cell lymphoma (AITL) is a kind of aggressive T-cell lymphoma with significant enrichment of non-malignant tumor microenvironment (TME) cells. However, the complexity of TME in AITL progression is poorly understood. We performed single-cell RNA-Seq (scRNA-seq) and imaging mass cytometry (IMC) analysis to compare the cellular composition and spatial architecture between relapsed/refractory AITL (RR-AITL) and newly diagnosed AITL (ND-AITL).

View Article and Find Full Text PDF

Although rearrangement of the MYC oncogene (MYC-R) is frequently observed in aggressive B-cell lymphomas, it is extremely rare in T-cell malignancies. A 64-year-old man who had been under observation for several years because of asymptomatic pulmonary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALToma) was admitted to our hospital because of poor general condition and hypotension. Blood tests revealed thrombocytopenia and elevated serum lactate dehydrogenase levels, whereas computed tomography revealed systemic lymphadenopathy and splenomegaly.

View Article and Find Full Text PDF
Article Synopsis
  • Angioimmunoblastic T-cell lymphoma (AITL) is a rare type of non-Hodgkin lymphoma that can show various clinical symptoms, and this report discusses a specific case where it was accompanied by pulmonary arterial hypertension (PAH).
  • An 84-year-old man with a history of gastric cancer showed symptoms like shortness of breath and was found to have lymphadenopathy, pleural effusion, and severe PAH, leading to the diagnosis of AITL through comprehensive testing.
  • The patient responded well to a mini-CHOP chemotherapy treatment, significantly improving his PAH and symptoms, reaching complete remission, highlighting the need to consider AITL in patients presenting with symptoms like PAH.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to identify clinical factors affecting survival and treatment outcomes for patients with angioimmunoblastic T-cell lymphoma (AITL) and to create a new prognostic model for this disease.
  • An analysis of 231 AITL patients showed a median age of 63, with most in advanced stages, and the overall survival (OS) and progression-free survival (PFS) were 17 months and 6 months, respectively.
  • The newly developed prognostic model categorizes patients into risk groups based on factors such as age and performance status, allowing for better prediction of survival outcomes, though there's still no clear consensus on the best initial treatment for AITL.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!